Innospec Inc. $IOSP Shares Purchased by Numerai GP LLC

Numerai GP LLC grew its holdings in shares of Innospec Inc. (NASDAQ:IOSP) by 29.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 81,541 shares of the specialty chemicals company’s stock after purchasing an additional 18,649 shares during the quarter. Innospec makes up about 0.9% of Numerai GP LLC’s portfolio, making the stock its 16th biggest holding. Numerai GP LLC’s holdings in Innospec were worth $6,292,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of IOSP. Versant Capital Management Inc raised its position in shares of Innospec by 378.1% in the third quarter. Versant Capital Management Inc now owns 545 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 431 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Innospec by 1,159.5% during the second quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock worth $44,000 after acquiring an additional 487 shares during the last quarter. State of Wyoming grew its stake in Innospec by 27.5% during the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock valued at $67,000 after acquiring an additional 173 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Innospec by 75.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 1,317 shares of the specialty chemicals company’s stock valued at $101,000 after acquiring an additional 566 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its holdings in Innospec by 8.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 1,917 shares of the specialty chemicals company’s stock valued at $148,000 after acquiring an additional 155 shares during the last quarter. Hedge funds and other institutional investors own 96.64% of the company’s stock.

Insiders Place Their Bets

In other Innospec news, Director Larry Padfield sold 594 shares of Innospec stock in a transaction on Friday, February 27th. The stock was sold at an average price of $76.56, for a total value of $45,476.64. Following the sale, the director owned 9,453 shares in the company, valued at $723,721.68. The trade was a 5.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director David Landless sold 594 shares of the company’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $76.56, for a total value of $45,476.64. Following the completion of the transaction, the director directly owned 7,632 shares in the company, valued at approximately $584,305.92. This trade represents a 7.22% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 4,989 shares of company stock worth $391,889 in the last three months. 1.31% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently weighed in on IOSP shares. Zacks Research cut Innospec from a “hold” rating to a “strong sell” rating in a report on Thursday, February 19th. Wall Street Zen raised Innospec from a “hold” rating to a “buy” rating in a report on Saturday, December 13th. Finally, Weiss Ratings raised Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, February 19th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Reduce”.

Innospec Price Performance

NASDAQ:IOSP opened at $68.12 on Tuesday. The company’s 50-day moving average is $79.91 and its two-hundred day moving average is $78.17. Innospec Inc. has a 1-year low of $67.84 and a 1-year high of $99.77. The firm has a market capitalization of $1.69 billion, a price-to-earnings ratio of 14.56, a PEG ratio of 1.81 and a beta of 0.90.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, February 17th. The specialty chemicals company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.26 by $0.24. Innospec had a net margin of 6.56% and a return on equity of 10.18%. The firm had revenue of $455.60 million for the quarter, compared to analyst estimates of $460.87 million. During the same quarter in the previous year, the company earned $1.41 EPS. The business’s revenue for the quarter was down 2.4% compared to the same quarter last year. As a group, equities analysts anticipate that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.

About Innospec

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.